We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

BioAlliance appoints Pierre Morgon chief operating officer

This article was originally published in Scrip

28 Aug 2008

News

Executive Summary

BioAlliance Pharma (France), a speciality pharmaceutical company focused on the treatment of infections in cancer and HIV, has strengthened its management board with the appointment of Pierre Morgon as chief operating officer. He joins from Schering-Plough France, where he managed primary care operations in France for two years and the partnership with MSD. From 2004 to 2006, Mr Morgon was vice-president of hospital operations at Bristol-Myers Squibb, and from 2003 to 2004 he served as general manager of Yamanouchi Pharma France.